Danaher Corporation (0R2B.L)
USD 230.79
(-1.77%)
USD 230.79
(-1.77%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 7.49 Billion USD | -21.94% |
| 2022 | 9.48 Billion USD | -5.38% |
| 2021 | 10 Billion USD | 67.87% |
| 2020 | 6.54 Billion USD | 33.72% |
| 2019 | 4.6 Billion USD | 7.16% |
| 2018 | 4.27 Billion USD | -3.19% |
| 2017 | 4.33 Billion USD | 6.62% |
| 2016 | 3.92 Billion USD | 28.31% |
| 2015 | 3.06 Billion USD | 11.28% |
| 2014 | 4.54 Billion USD | -29.21% |
| 2013 | 4.6 Billion USD | 0.35% |
| 2012 | 4 Billion USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.74 Billion USD | -9.05% |
| 2024 Q1 | 1.89 Billion USD | 6.19% |
| 2024 Q3 | 1.65 Billion USD | -5.32% |
| 2023 Q4 | 1.9 Billion USD | -4.27% |
| 2023 FY | - USD | -22.99% |
| 2023 Q1 | 2.35 Billion USD | -18.08% |
| 2023 Q2 | 1.99 Billion USD | -15.31% |
| 2023 Q3 | 1.99 Billion USD | 0.05% |
| 2022 FY | - USD | -5.38% |
| 2022 Q4 | 2.87 Billion USD | 12.33% |
| 2022 Q3 | 2.55 Billion USD | -7.33% |
| 2022 Q2 | 2.75 Billion USD | 0.73% |
| 2022 Q1 | 2.73 Billion USD | -0.15% |
| 2021 Q1 | 2.53 Billion USD | 12.25% |
| 2021 Q2 | 2.53 Billion USD | -0.35% |
| 2021 Q3 | 2.43 Billion USD | -3.64% |
| 2021 Q4 | 2.74 Billion USD | 12.43% |
| 2021 FY | - USD | 67.87% |
| 2020 Q3 | 1.81 Billion USD | 19.29% |
| 2020 Q4 | 2.26 Billion USD | 24.42% |
| 2020 FY | - USD | 33.72% |
| 2020 Q1 | 1 Billion USD | -19.89% |
| 2020 Q2 | 1.52 Billion USD | 51.19% |
| 2019 FY | - USD | 7.16% |
| 2019 Q4 | 1.25 Billion USD | 16.94% |
| 2019 Q3 | 1.07 Billion USD | -3.51% |
| 2019 Q2 | 1.11 Billion USD | 9.22% |
| 2019 Q1 | 1.02 Billion USD | 23.79% |
| 2018 FY | - USD | -3.19% |
| 2018 Q2 | 1.21 Billion USD | 12.95% |
| 2018 Q4 | 824.7 Million USD | -28.98% |
| 2018 Q3 | 1.16 Billion USD | -4.06% |
| 2018 Q1 | 1.07 Billion USD | -24.72% |
| 2017 Q2 | 979.9 Million USD | 5.42% |
| 2017 Q1 | 929.5 Million USD | -25.5% |
| 2017 FY | - USD | 6.62% |
| 2017 Q4 | 1.42 Billion USD | 31.94% |
| 2017 Q3 | 1.07 Billion USD | 10.1% |
| 2016 Q2 | 987.7 Million USD | 12.14% |
| 2016 Q1 | 880.8 Million USD | -19.05% |
| 2016 Q3 | 976.3 Million USD | -1.15% |
| 2016 FY | - USD | 28.31% |
| 2016 Q4 | 1.24 Billion USD | 27.79% |
| 2015 FY | - USD | 11.28% |
| 2015 Q4 | 1.08 Billion USD | 76.55% |
| 2015 Q3 | 616.3 Million USD | 20.25% |
| 2015 Q2 | 512.5 Million USD | -48.26% |
| 2015 Q1 | 990.6 Million USD | -20.06% |
| 2014 FY | - USD | -29.21% |
| 2014 Q4 | 1.23 Billion USD | 15.75% |
| 2014 Q1 | 1.01 Billion USD | -17.46% |
| 2014 Q3 | 1.07 Billion USD | 0.99% |
| 2014 Q2 | 1.06 Billion USD | 4.59% |
| 2013 Q3 | 1.03 Billion USD | -2.4% |
| 2013 Q2 | 1.06 Billion USD | 12.19% |
| 2013 FY | - USD | 0.35% |
| 2013 Q1 | 947.7 Million USD | -10.89% |
| 2013 Q4 | 1.22 Billion USD | 18.34% |
| 2012 Q4 | 1.06 Billion USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 7384.472% |
| Accuray Incorporated | 9 Million USD | -83138.983% |
| Align Technology, Inc. | 799.03 Million USD | -838.502% |
| Elevance Health Inc. | 10.49 Billion USD | 28.513% |
| AxoGen, Inc. | -13.32 Million USD | 56365.006% |
| Boston Scientific Corporation | 3.61 Billion USD | -107.556% |
| CVS Health Corporation | 18.17 Billion USD | 58.747% |
| Cardinal Health, Inc. | 1.97 Billion USD | -279.12% |
| Centene Corporation | -463 Million USD | 1719.654% |
| DaVita Inc. | 2.34 Billion USD | -219.59% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 41.05% |
| Hologic, Inc. | 1.29 Billion USD | -478.537% |
| Humana Inc. | -561 Million USD | 1436.72% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -515.851% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -455.728% |
| Masimo Corporation | 236.7 Million USD | -3068.145% |
| McKesson Corporation | 4.66 Billion USD | -60.681% |
| Patterson Companies, Inc. | 374.75 Million USD | -1901.035% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -332.968% |
| ResMed Inc. | 1.6 Billion USD | -368.591% |
| Henry Schein, Inc. | 943 Million USD | -695.228% |
| Teladoc Health, Inc. | 153.99 Million USD | -4769.575% |
| Universal Health Services, Inc. | 1.74 Billion USD | -330.131% |
| Veeva Systems Inc. | 429.33 Million USD | -1646.659% |
| Baxter International Inc. | 2.77 Billion USD | -170.137% |
| Becton, Dickinson and Company | 4.27 Billion USD | -75.415% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -213.228% |
| Stryker Corporation | 5.16 Billion USD | -45.329% |
| Medtronic plc | 9.05 Billion USD | 17.193% |